Skip to main content

Vireo Growth Inc. (VREOF)

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Last price
$6.29
As of

Kresmion compiles this page from VREOF's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Vireo Growth Inc. (VREOF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-17.

As of . Source: SEC EDGAR filings for VREOF. Method and limitations.

COMPANY DOSSIER

See the full VREOF dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for VREOF on one page. Preview it with sample data, then open it live with a free account.

Preview the VREOF dossier

Active events for VREOF

  • mediumEarnings below estimates

    Q3-2026: Missed consensus by 244.9%, EPS $-0.34 vs $0.2346 estimate

FREE, NO ACCOUNT

Every event on VREOF, as it fires

New filings, 13F moves and cross asset events on VREOF land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, VREOF

More data on VREOF

VREOF against its peers

VREOF's operating margin of -0.4% ranks in the 69th percentile of 17 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-05-31.

MetricVREOFPeer medianPercentilen
Revenue FY269M USD181M USD6816
Gross margin47.3%50.3%4217
Operating margin-0.4%-11.0%6917
Net margin-25.3%-18.7%4217
Return on equity-22.2%-25.1%5315
1 year-50.1%-31.7%3319

Peers (19): TLRY, VRNO, NIKA, ELTP, EOLS, KMDA, AQST, TKNO, CGC, CRLBF, ADCT, AKBA, CRDL, DERM, GLAS, HROW, TSNDF, BGM, CRON. Left out: BORAY (no annual filing), LFCR (no annual filing), EVO (period gap), ASRT.D (no annual filing), PHBI (period gap), OGI (period gap). Fiscal periods ending between 2025-09-30 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (VREOF: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in VREOF on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on VREOF in the last 180 days.

Upstream: SEC EDGAR filings for VREOF

Kresmion, "Vireo Growth Inc. (VREOF) institutional holdings and SEC filings", data as of 2026-11-17, https://kresmion.com/research/VREOF. Upstream data: SEC EDGAR filings for VREOF.

Link to this data (HTML):

<a href="https://kresmion.com/research/VREOF">Vireo Growth Inc. (VREOF) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow VREOF on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to VREOF for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the VREOF dossier
Share

The VREOF intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.